Second patient death reported with gene therapy for muscular dystrophy
By MATTHEW PERRONE, Associated Press WASHINGTON (AP) — Shares of Sarepta Therapeutics plunged Monday after the biotech drugmaker reported a second death in connection with its gene therapy for muscular dystrophy. Sarepta reported the death over the weekend and provided … Continued